132 related articles for article (PubMed ID: 11202193)
1. [Cyclophosphamide-induced apoptosis of murine lymphosarcoma cells in vivo].
Kaledin VI; Nikolin VP; Ageeva TA; Timofeeva OA; Filipenko ML; Ronichevskaia GM; Morozkova TS; Popova NA; Baĭmak TIu
Vopr Onkol; 2000; 46(5):588-93. PubMed ID: 11202193
[TBL] [Abstract][Full Text] [Related]
2. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effectiveness of mono- and polychemotherapy for murine lymphosarcoma, resistant to apoptosis induction].
Kaledin VI; Popova NA; Andreeva EM
Vopr Onkol; 2006; 52(1):70-3. PubMed ID: 16715708
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis.
Korolenko TA; Poteryaeva ON; Djanayeva SJ; Svechnikova IG; Kaledin VI; Timofeyeva OA; Filipenko ML; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):285-92. PubMed ID: 11345040
[TBL] [Abstract][Full Text] [Related]
5. Influence of Ukrain and cyclophosphamide administration on HA-1 murine hepatoma and LS lymphoma on aspartic proteinase cathepsin D.
Djanayeva SJ; Korolenko TA; Svechnikova IG; Falameyeva OV; Korolenko E; Kaledin VI; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):293-9. PubMed ID: 11345041
[TBL] [Abstract][Full Text] [Related]
6. [The effect of cycloferon administration on the growth of transplantable tumors in rats and mice].
Zabezhinskiĭ MA; Popovich IG; Shtylik AV; Kovalenko AL; Anisimov VN
Vopr Onkol; 1998; 44(4):427-31. PubMed ID: 9807206
[TBL] [Abstract][Full Text] [Related]
7. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
[TBL] [Abstract][Full Text] [Related]
8. Chitotriosidase as a new marker of macrophage stimulation in a tumor model treated with cyclophosphamide and Ukrain.
Korolenko TA; Djanayeva SJ; Falameyeva OV; Wevers RA; Filjushina EE; Buzueva II; Kaledin VI; Sandula J; Nowicky J
Drugs Exp Clin Res; 2000; 26(5-6):279-83. PubMed ID: 11345039
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-beta and anti-CD20 monoclonal antibodies for treatment of human non-Hodgkin's lymphomas.
Pagel JM; Laugen C; Bonham L; Hackman RC; Hockenbery DM; Bhatt R; Hollenback D; Carew H; Singer JW; Press OW
Clin Cancer Res; 2005 Jul; 11(13):4857-66. PubMed ID: 16000584
[TBL] [Abstract][Full Text] [Related]
10. mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.
Cejka D; Preusser M; Fuereder T; Sieghart W; Werzowa J; Strommer S; Wacheck V
Anticancer Res; 2008; 28(6A):3801-8. PubMed ID: 19189667
[TBL] [Abstract][Full Text] [Related]
11. Mouse lymphosarcomas sensitive and resistant to cyclophosphamide therapy: activity of cathepsins B, L, and D during various schemes of treatment with cyclophosphamide and SE-glycan.
Usova TA; Zhanaeva SY; Kogan G; Shandula I; Korolenko TA
Bull Exp Biol Med; 2003 Nov; 136(5):451-4. PubMed ID: 14968157
[TBL] [Abstract][Full Text] [Related]
12. [A case of the successful use of nitrosomethylurea in lymphosarcoma complicated by prolonged massive chylothorax].
Korman DB; Snimshchikov VA
Vopr Onkol; 1992; 38(7):859-61. PubMed ID: 1300793
[No Abstract] [Full Text] [Related]
13. Effect of Paclitaxel on Antitumor Activity of Cyclophosphamide: Study on Two Transplanted Tumors in Mice.
Kaledin VI; Nikolin VP; Popova NA; Pyshnaya IA; Bogdanova LA; Morozkova TS
Bull Exp Biol Med; 2015 Nov; 160(1):81-3. PubMed ID: 26597686
[TBL] [Abstract][Full Text] [Related]
14. Activation of cathepsins B and L in mouse lymphosarcoma tissue under the effect of cyclophosphamide is associated with apoptosis induction and infiltration by mononuclear phagocytes.
Zhanaeva SY; Mel'nikova EV; Trufakin VA; Korolenko TA
Bull Exp Biol Med; 2013 Nov; 156(1):86-90. PubMed ID: 24319737
[TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
Wang X; Zhang J; Xu T
Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of total saponins from stem and leaf of Panax ginseng against cyclophosphamide-induced genotoxicity and apoptosis in mouse bone marrow cells and peripheral lymphocyte cells.
Zhang QH; Wu CF; Duan L; Yang JY
Food Chem Toxicol; 2008 Jan; 46(1):293-302. PubMed ID: 17904265
[TBL] [Abstract][Full Text] [Related]
17. In vivo targeting of dead tumor cells in a murine tumor model using a monoclonal antibody specific for the La autoantigen.
Al-Ejeh F; Darby JM; Pensa K; Diener KR; Hayball JD; Brown MP
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5519s-5527s. PubMed ID: 17875784
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide-induced tumour regression of cyclophosphamide-resistant L5178Y lymphoma through suppressor cells elimination.
Andrade-Mena CE
Int J Tissue React; 1994; 16(2):95-103. PubMed ID: 7960506
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
[TBL] [Abstract][Full Text] [Related]
20. Astaxanthin inhibits cytotoxic and genotoxic effects of cyclophosphamide in mice germ cells.
Tripathi DN; Jena GB
Toxicology; 2008 Jun; 248(2-3):96-103. PubMed ID: 18485558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
